Takayuki Kishikawa

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Combination Therapy

Tyrosine Kinase

Small Cell Lung Cancer

Top Venues

Thoracic cancer

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Hisao Imai, Satoshi Wasamoto, Takeshi Tsuda, Yoshiaki Nagai, Takayuki Kishikawa, Ken Masubuchi, Takashi Osaki, Yosuke Miura, Yukihiro Umeda, Akihiro Ono, Hiroyuki Minemura, Yutaka Yamada, Junichi Nakagawa, Yuki Kozu, Hirokazu Taniguchi, Hiromitsu Ohta, Takashi Kasai, Kyoichi Kaira, Hiroshi Kagamu
Using the neutrophil-to-lymphocyte ratio to predict the outcome of individuals with nonsquamous non-small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed. Thoracic cancer (2023)
Ken Masubuchi, Hisao Imai, Satoshi Wasamoto, Takeshi Tsuda, Hiroyuki Minemura, Yoshiaki Nagai, Yutaka Yamada, Takayuki Kishikawa, Yukihiro Umeda, Ayako Shiono, Hiroki Takechi, Jun Shiihara, Kyoichi Kaira, Kenya Kanazawa, Hirokazu Taniguchi, Takayuki Kaburagi, Hiroshi Kagamu, Koichi Minato
Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival. Thoracic cancer 13 (19) (2022)
Hisao Imai, Takayuki Kishikawa, Hiroyuki Minemura, Yutaka Yamada, Tatsuya Ibe, Ou Yamaguchi, Atsuto Mouri, Yoichiro Hamamoto, Kenya Kanazawa, Takashi Kasai, Kyoichi Kaira, Takayuki Kaburagi, Koichi Minato, Kunihiko Kobayashi, Hiroshi Kagamu
Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer. Cancer medicine 10 (20) (2021)
Takayuki Kishikawa, Takashi Kasai, Masahiko Okada, Ichiro Nakachi, Sayo Soda, Ryo Arai, Ayako Takigami, Masafumi Sata
Osimertinib, a third-generation EGFR tyrosine kinase inhibitor: A retrospective multicenter study of its real-world efficacy and safety in advanced/recurrent non-small cell lung carcinoma. Thoracic cancer 11 (4) (2020)
Hisao Imai, Hiroyuki Minemura, Takayuki Kishikawa, Yutaka Yamada, Kensuke Suzuki, Yukihiro Umeda, Satoshi Wasamoto, Norimitsu Kasahara, Shinichi Ishihara, Ou Yamaguchi, Ichiro Naruse, Junji Uchino, Keita Mori, Kenya Kanazawa, Yoko Shibata, Takashi Kasai, Takayuki Kaburagi, Kyoichi Kaira, Koichi Minato
Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis. Thoracic cancer 11 (10) (2020)